Search results
Dec 7, 2023 · That said, Eli Lilly says that the drug can cost as little as $25 a month when you enroll in a commercial card savings program (more on that in a moment). It could also cost $550 a month...
Get Zepbound for as low as $1,052.25, which is 19% off the average retail price of $1,303.10 for the most common version, by using a GoodRx coupon.
Understand your cost and coverage options for Zepbound®. Learn more about the Zepbound Savings Card and LillyDirect™️, an online pharmacy solutions option.
For eligible and commercially insured patients, help them learn more about the cost and coverage with the Zepbound® savings card.
Dec 20, 2023 · Zepbound (tirzepatide), a prescription-only medication FDA approved for weight management in November 2023, will launch with a list price of $1,060 for a 28-day supply. If you have insurance or qualify for manufacturer savings, you’ll likely pay less for the medication.
Dec 19, 2023 · How Much Does Zepbound Cost? The list price for Zepbound from Eli Lilly is $1,059.87, which the company says doesn’t reflect what people may pay with insurance coverage.
Zepbound is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. Zepbound should be used with a reduced-calorie diet and increased physical activity.
Nov 8, 2023 · People who are commercially insured without coverage for Zepbound may be eligible to pay as low as $550 for a 1-month prescription of Zepbound, approximately 50% lower than the list price. People may begin using the savings card program in the days following product availability at U.S. pharmacies.
Nov 9, 2023 · Key Takeaways. The FDA approved Eli Lilly’s Zepbound, a new medication to assist in weight management for adults with obesity. Zepbound uses the same active ingredient, tirzepatide, as the type 2 diabetes medication Mounjaro.
Nov 8, 2023 · Zepbound will cost about $1,060 per month before insurance, Eli Lilly said in its own news release, and the company said in a media briefing it would be on pharmacy shelves after the...
